Genomic Health, Inc. (GHI) is seeking an exceptional clinical investigator in Prostate/urologic oncology with a strong interest in personalized medicine to provide clinical leadership in the development of tests and services that will transform cancer patient care. The Director/Sr. Director of Urologic (Prostate) Oncology Development will be responsible for providing clinical leadership of development programs resulting in the successful and timely launch of new products and services and line extensions for marketed products. Genomic Health is building upon the success of the Oncotype DX breast cancer assay with a growing number of programs, including those in prostate, bladder and kidney that are developing tissue- and liquid-based assays in order to drive precision oncology. Specifically, following the successful launch of the Oncotype DX Genomic Prostate Score, Genomic Health is creating a portfolio of products and services to bring precision medicine into the practice of Urology.
To support these programs, the Director/Sr. Director will be responsible for clinical vision and oversight during the investigation, development, and commercial stages of new and existing products including the design and execution of clinical validation and utility studies. Clinical study leadership includes initiating and managing external collaborations with leaders in urologic oncology, cooperative groups, and research organizations, identifying investigators to participate in key clinical trials, and reviewing, interpreting, and presenting key results. The Director/Sr. Director of Urologic Oncology will also provide clinical support for due diligence in relevant business development activities.
The successful candidate will be a key member of the multi-functional Core Team including leaders from Research and Development, Product Lifecycle Management, Laboratory Operations, and the Commercial Organization and a leader in urologic oncology across Genomic Health. This role is also expected to significantly contribute to the Oncology Development organization by contributing to the development of strategies for generating clinical validation and utility data. The Director/Sr. Director for Oncology Development will report to the Chief Medical Officer.